A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products (S5059-119) explained: What It Does, Why It Matters

Legal Insight for a Changing World

A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products (S5059-119) explained: What It Does, Why It Matters | The Daily Law